Ropes & Gray represented Ultragenyx Pharmaceuticals, a development-stage biotechnology company focused on the identification, acquisition, development, and commercialization of various products for the treatment of rare and ultra-rare diseases, in its $120 million initial public offering.
The Ropes & Gray team included benefits counsel Allie Alperovich.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.